FDA Approves Drug For Treatment Of Recurrent Clostridioides Difficile Infections

Reuters (4/26, Mahobe, Samal) reports that the FDA “on Wednesday approved Seres Therapeutics Inc’s pill for treating” recurrent Clostridioides difficile infections (CDI), “giving an easier and standardized option to patients who often have to rely on indi...